This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
17 Jul 2017 | North America
US Oncology Diagnostics Market, Forecast to 2021
Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection
Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consoli...
$4,950.00 -
30 Jun 2017 | Europe
Growth Opportunities in the Western European Oncology Diagnostics Market, Forecast to 2021
Data-driven Solutions and Co-development are Key Growth Drivers
The Western European Oncology Diagnostics Market, Forecast to 2021 study presents an overview of the oncology diagnostics market landscape in the Western European countries, with a focus on EU 5. The analysis provides forecasts for the EU 5 markets, segmented by types of cancer, which include breast cancer, ovarian cancer, cervical cancer, prostate...
$4,950.00 -
23 Jun 2017 | Europe
Growth Opportunities in the Western European IVD Industry, Forecast to 2021
Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions
Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the ...
$4,950.00 -
22 Jun 2017 | Asia Pacific
Malaysia, Singapore, and Indonesia Transformational Health Insights, 2017–2022
Rapid Growth, Reforms, and Partnerships are Transforming Healthcare Systems in Malaysia, Singapore, and Indonesia
Southeast Asia (SEA) is emerging as the gold mine for both local and international healthcare vendors. Within SEA, Malaysia, Singapore, and Indonesia still have unexplored and under-served markets providing boundless opportunities for healthcare vendors with innovative products and services. To be able to capitalize on the market, medical device ma...
$1,500.00 -
20 Jun 2017 | North America
Transformation and Growth Opportunities in the US Next-Generation Sequencing Informatics Market
Pharmaceutical and Molecular Diagnostics Segments to Lead Revenue Growth
Frost & Sullivan expects strong demand for commercial application-focused solutions to drive new investments in the development of tools and technologies, and will also result in consolidation of the US next-generation sequencing informatics market. Changing customer requirements and intense competition will drive the transformation. As companies l...
$4,950.00 -
19 Jun 2017 | Asia Pacific
Growth Opportunities in the APAC IVD Market, Forecast to 2021
Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market
The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016. Research Scope: • Key trends and opportunities in the IVD market, which has been segmented into 8 major divisions: o Immunochemistry o Self-monitoring Blood Glucose (SMBG) Meter o Hematology o Point-of-care...
$4,950.00 -
31 May 2017 | Europe
Growth Opportunities in the European Next-generation Sequencing Informatics Market, Forecast to 2021
Big-data-driven Clinical Interpretation in Novel Areas is Set to Drive Market Growth
The cost of genomic sequencing has significantly declined in the recent past with the utilization of high-throughput sequencers creating opportunities for Next-generation Sequencing (NGS) informatics to develop genetic insights from the growing volume of sequencing data. As NGS technologies mature and the market stakeholders develop clarity on indu...
$4,950.00 -
23 May 2017 | North America
Growth Opportunities in the US In Vitro Diagnostics (IVD) Market, Forecast to 2021
US IVD Market Witnesses Pricing Fluctuations Due to the PAMA Regulation
The In Vitro Diagnostics (IVD) landscape in the United States is extremely dynamic, with a high level of merger and acquisition activity with many high-value deals still pending. Both clinical laboratories and manufacturers are increasingly vying for smaller specialized niche technology companies to increase their market share. Molecular point of c...
$4,950.00 -
19 May 2017 | Global
Innovations in Medical Device Technologies
The latest issue of the Medical Devices TOE profiles innovations across the innovation ecosystem and the breadth of the medical devices industry. These include innovations from university research labs, start-up companies, corporations and findings from clinical trials. The innovations come from diverse fields such as super-capacitors for implantab...
$950.00 -
19 May 2017 | Global
Recent Advances in Cancer Immunotherapy and Tumor Profiling Technologies
Cancer immunotherapy and cancer profiling are key areas of growth across the healthcare community. These vital areas will define the future of how cancer is screened, diagnosed, managed, and monitored. With technology areas such as exosome technology being implemented in profiling tumors, a paradigm shift can be brought about in how cancer is detec...
$250.00
